↑ Rising
Business
Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Dupixent
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 holds ✗
Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.